Skip to main content
. 2022 Aug 19;28(21):4634–4641. doi: 10.1158/1078-0432.CCR-22-1268

Table 3.

Summary of CT900 plasma pharmacokinetic parameters from dose escalation phase, Cycle 1 Day 1.

Cohort (mg/m2) Descriptive statistic T max (h) C max (ng/mL) HL Lambda_z (h) AUC0-24 (h.ng/mL) AUClast (h.ng/mL) Cl (mL/h) Vss (mL)
1 Mean 1.0 402 6.7 1,654 1,654 1,219 7,594
CV% 1.7 7.2 47.6 39.7 39.7 47.7 19.7
Geometric Mean 1.0 402 6.1 1,565 1,565 1,116 7,501
CV% Geo Mean 1.8 7.2 62.2 43.4 43 57.6 19.0
Median 1.0 401 7.5 1,618 1,618 1,250 6,745
Range 1.0–1.0 374–432 3.2–9.4 1,017–2,329 1,017–2,329 623–1,784 6,712–9,324
N 3 3 3 3 3 3 3
2 Mean 0.9 746 12.6 4,892 6,857 674 8,519
CV% 29.6 14.4 42.1 42.9 63.0 75.1 34.2
Geometric Mean 0.9 740 11.8 4,541 5,855 552 8,193
CV% Geo Mean 37.1 14.9 41.9 48.2 75 82.6 32.1
Median 1.0 759 11.3 4,733 6,046 523 7,407
Range 0.5–1.1 613–855 7.5–20.0 2,516–7,588 2,516–12,818 244–1,405 6,534–12,730
N 4 4 4 4 4 4 4
6 Mean 1.0 2,030 19.9 15,104 25,574 460 12,024
N 1 1 1 1 1 1 1
12 Mean 1.0 5,132 28.7 47,191 87,560 216 7,621
CV% 1.4 12.4 24.6 13.9 23.5 29.6 11.1
Geometric Mean 1.0 5,101 28.1 46,862 85,858 207 7,586
CV% Geo Mean 1.4 12.2 22.4 13.0 22 33.0 10.6
Median 1.0 4,830 26.5 45,428 83,497 221 7,333
Range 1.0–1.0 4,460–6,010 23.0–41.0 42,328–58,611 68,732–122,559 126–303 6,986–9,065
N 5 5 5 5 5 5 5

Abbreviations: CV%, percentage coefficient of variation; Tmax, time to maximum observed plasma concentration; Cmax, maximum observed plasma concentration; HL λz, half-life terminal rate constant; AUC0-24, area under the plasma concentration versus time curve from 0 to 24 hours; AUClast, area under the plasma concentration versus time curve from 0 to the last value above the limit of quantification; Cl, clearance; Vss, steady state volume of distribution.